Non-invasive Prenatal Test (NIPT) is a safe and highly accurate test that only requires the collection of blood from pregnant women to test for fetal chromosomal abnormalities. In addition to the common trisomy disorders (Down syndrome, Edward syndrome, and Batau syndrome), we have also developed tests for microdeletion syndromes (NIPT2.0) and skeletal dysplasia-related mutations (NIPT3.0) to provide more comprehensive early screening programs.

One-stop service with implementable programs in Taiwan.
Certified by TAF and LDTS (TFDA), the testing quality is guaranteed.